Brian G. Atwood's Insider Trades & SAST Disclosures
Brian G. Atwood's most recent trade in CERo Therapeutics Holdings Inc. was a trade of 294,460 Pre-Funded Warrant done . Disclosure was reported to the exchange on March 31, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Brian G. Atwood.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| CERo Therapeutics Holdings... | Brian G. Atwood | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2025 | 294,460 | 11,660 | - | - | Pre-Funded Warrant | |
| CERo Therapeutics Holdings... | Brian G. Atwood | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2025 | 294,460 | 490,534 | - | 0.0 | 29 | Common Stock |
| CERo Therapeutics Holdings... | Brian G. Atwood | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 14,936 | 14,936 | - | - | Stock Option (Right to Buy) | |
| CERo Therapeutics Holdings... | Brian G. Atwood | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 254,000 | 508,000 | - | - | Stock Option (Right to Buy) | |
| CERo Therapeutics Holdings... | Brian G. Atwood | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2025 | 306,120 | 306,120 | - | - | Pre-Funded Warrant | |
| CERo Therapeutics Holdings... | Brian G. Atwood | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2025 | 306,120 | 306,120 | - | - | Warrant to Purchase Shares of Common Stock | |
| CERo Therapeutics Holdings... | Brian G. Atwood | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2025 | 204,080 | 204,080 | - | - | Pre-Funded Warrant | |
| CERo Therapeutics Holdings... | Brian G. Atwood | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2025 | 204,080 | 204,080 | - | - | Warrant to Purchase Shares of Common Stock | |
| CERo Therapeutics Holdings... | Brian G. Atwood | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2024 | 254,000 | 254,000 | - | - | Stock Option (Right to Buy) | |
| CERo Therapeutics Holdings... | Brian G. Atwood | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Sep 2024 | 19,358,578 | 19,607,313 | - | - | Common Stock | |
| CERo Therapeutics Holdings... | Brian G. Atwood | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 25 Sep 2024 | 1,317,956 | 0 | - | - | Stock Option (Right to Buy) | |
| CERo Therapeutics Holdings... | Brian G. Atwood | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 25 Sep 2024 | 13,857 | 0 | - | - | Stock Option (Right to Buy) | |
| CERo Therapeutics Holdings... | Brian G. Atwood | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Sep 2024 | 1,002 | 0 | - | - | Series A Convertible Preferred Stock | |
| CERo Therapeutics Holdings... | Brian G. Atwood | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2024 | 1,317,956 | 1,317,956 | - | - | Stock Option (Right to Buy) | |
| CERo Therapeutics Holdings... | Brian G. Atwood | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 14 Feb 2024 | 148,208 | 248,735 | - | - | Common Stock | |
| CERo Therapeutics Holdings... | Brian G. Atwood | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 14 Feb 2024 | 148,208 | 248,735 | - | - | Common Stock | |
| CERo Therapeutics Holdings... | Brian G. Atwood | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 14 Feb 2024 | 100,527 | 100,527 | - | - | Common Stock | |
| CERo Therapeutics Holdings... | Brian G. Atwood | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 14 Feb 2024 | 100,527 | 100,527 | - | - | Common Stock | |
| CERo Therapeutics Holdings... | Brian G. Atwood | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 13,857 | 13,857 | - | - | Stock Option (Right to Buy) | |
| CERo Therapeutics Holdings... | Brian G. Atwood | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 1,002 | 1,002 | - | - | Series A Convertible Preferred Stock | |
| CERo Therapeutics Holdings... | Brian G. Atwood | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 1,002 | 1,002 | - | - | Series A Convertible Preferred Stock | |
| Atreca Inc - Ordinary Shar... | Brian G. Atwood | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 12,000 | 12,000 | - | - | Stock Option (right to buy) | |
| Atreca Inc - Ordinary Shar... | Brian G. Atwood | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 12,000 | 12,000 | - | - | Stock Option (right to buy) | |
| Atreca Inc - Ordinary Shar... | Brian G. Atwood | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2021 | 12,000 | 12,000 | - | - | Stock Option (right to buy) | |
| Atreca Inc - Ordinary Shar... | Brian G. Atwood | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Dec 2020 | 34,166 | 34,166 | - | - | Stock Option (right to buy) | |
| Atreca Inc - Ordinary Shar... | Brian G. Atwood | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Dec 2020 | 34,166 | 0 | - | - | Stock Option (right to buy) | |
| Atreca Inc - Ordinary Shar... | Brian G. Atwood | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Dec 2020 | 12,500 | 12,500 | - | - | Stock Option (right to buy) | |
| Atreca Inc - Ordinary Shar... | Brian G. Atwood | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Dec 2020 | 12,500 | 0 | - | - | Stock Option (right to buy) | |
| Atreca Inc - Ordinary Shar... | Brian G. Atwood | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Dec 2020 | 12,000 | 0 | - | - | Stock Option (right to buy) | |
| Atreca Inc - Ordinary Shar... | Brian G. Atwood | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Dec 2020 | 12,000 | 12,000 | - | - | Stock Option (right to buy) | |
| Atreca Inc - Ordinary Shar... | Brian G. Atwood | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2020 | 12,000 | 12,000 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges